These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21159398)

  • 1. Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans.
    Athar BS; Paganetti H
    Radiother Oncol; 2011 Jan; 98(1):87-92. PubMed ID: 21159398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patients.
    Athar BS; Bednarz B; Seco J; Hancox C; Paganetti H
    Phys Med Biol; 2010 May; 55(10):2879-91. PubMed ID: 20427856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
    Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
    Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors.
    Moteabbed M; Yock TI; Paganetti H
    Phys Med Biol; 2014 Jun; 59(12):2883-99. PubMed ID: 24828559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
    Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
    Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of out-of-field dose and its constituent components for intensity-modulated radiation therapy versus conformal radiation therapy: implications for carcinogenesis.
    Ruben JD; Lancaster CM; Jones P; Smith RL
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1458-64. PubMed ID: 20950947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer.
    Fontenot JD; Lee AK; Newhauser WD
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):616-22. PubMed ID: 19427561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.
    Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ
    Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.
    Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
    Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
    Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT).
    Casey DL; Friedman DN; Moskowitz CS; Hilden PD; Sklar CA; Wexler LH; Wolden SL
    Pediatr Blood Cancer; 2015 Feb; 62(2):311-316. PubMed ID: 25328040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential dosimetric benefit of proton beam therapy over intensity modulated radiotherapy for a variety of targets in patients with intracranial germ cell tumors.
    Park J; Park Y; Lee SU; Kim T; Choi YK; Kim JY
    Radiat Oncol; 2015 Jun; 10():135. PubMed ID: 26112360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the radiation-induced second cancer risk in proton therapy for pediatric brain tumors: the impact of employing a patient-specific aperture in pencil beam scanning.
    Geng C; Moteabbed M; Xie Y; Schuemann J; Yock T; Paganetti H
    Phys Med Biol; 2016 Jan; 61(1):12-22. PubMed ID: 26605679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy.
    Dennis ER; Bussiere MR; Niemierko A; Lu MW; Fullerton BC; Loeffler JS; Shih HA
    Technol Cancer Res Treat; 2013 Feb; 12(1):1-9. PubMed ID: 22775339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of IMRT and proton radiotherapy on secondary cancer incidence.
    Schneider U; Lomax A; Pemler P; Besserer J; Ross D; Lombriser N; Kaser-Hotz B
    Strahlenther Onkol; 2006 Nov; 182(11):647-52. PubMed ID: 17072522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.
    Brodin NP; Munck Af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Vogelius IR; Nilsson P; Lannering B; Björk-Eriksson T
    Acta Oncol; 2011 Aug; 50(6):806-16. PubMed ID: 21767178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.
    Lomax AJ; Cella L; Weber D; Kurtz JM; Miralbell R
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):785-92. PubMed ID: 12573766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
    Hall EJ
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.